{"disease":{"id":"treatment-for-prevention-of-chronic-migraine","name":"treatment for prevention of chronic migraine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02066415","title":"A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":667,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02174861","title":"A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"Amgen","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}